Literature DB >> 35753852

Cannabis smoking and age-related macular degeneration in the UK Biobank cohort.

S Lehrer1, P H Rheinstein2.   

Abstract

BACKGROUND: A major cause of blindness in older persons is age-related macular degeneration (AMD). Cigarette smoking is one of the major risk factors for AMD. In the present study, we analyzed UK Biobank data to determine whether smoking cannabis, like cigarettes, might be related to AMD.
METHODS: Our UK Biobank application was approved as UKB project 57245 (S.L., P.H.R.). Our analysis included all subjects with AMD and cannabis smoking information. The diagnosis of AMD was ascertained based on the 10th Revision of the International Classification of Diseases (ICD10), H35.3. Age at time of diagnosis of AMD was obtained from data field 5923. Cannabis information was recorded in UKB category 143, data field 20453, ever taken cannabis. A touch screen posed the question, "Have you taken CANNABIS (cannabis, grass, hash, ganja, blow, draw, skunk, weed, spliff, dope), even if it was a long time ago?" Possible answers were no, yes, 1-2 times, yes 3-10 times, yes, 11-100 times, yes, more than 100 times.
RESULTS: Subjects who had used marijuana more than 100 times had a significantly reduced risk of AMD, compared to subjects who had never used marijuana, and use of marijuana every day was associated with less AMD than use of marijuana less than once a month. But subjects who used cannabis 100 times or more were significantly younger (8years) when they developed AMD than subjects who never used cannabis.
CONCLUSION: Drusen, deposits of lipids, proteins, and cellular debris, accumulate in Bruch's membrane, limiting transport between the retinal pigment epithelium and the vasculature, triggering an inflammatory reaction. Marijuana can retard the inflammatory process because it is a powerful anti-inflammatory agent. Therefore, marijuana could reduce the risk of AMD. At the same time, blood vessels in the choriocapillaris below Bruch's membrane become more sparse with age. This phenomenon is believed to be a starting point for AMD. Marijuana can accelerate the loss of blood vessels due to its anti-angiogenic properties. Therefore, marijuana use might cause AMD to develop sooner in younger people.
Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cannabis; Goudron; Retina; Rétine; Tar; Toxicity; Toxicité

Mesh:

Year:  2022        PMID: 35753852      PMCID: PMC9444905          DOI: 10.1016/j.jfo.2022.01.004

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   1.194


  11 in total

1.  Smoking and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.

Authors:  Jennifer S L Tan; Paul Mitchell; Annette Kifley; Victoria Flood; Wayne Smith; Jie Jin Wang
Journal:  Arch Ophthalmol       Date:  2007-08

Review 2.  Cannabis smoking and respiratory health: consideration of the literature.

Authors:  Peter Gates; Adam Jaffe; Jan Copeland
Journal:  Respirology       Date:  2014-05-15       Impact factor: 6.424

Review 3.  New insights into antimetastatic and antiangiogenic effects of cannabinoids.

Authors:  Robert Ramer; Burkhard Hinz
Journal:  Int Rev Cell Mol Biol       Date:  2014-12-18       Impact factor: 6.813

4.  The quest to treat dry age-related macular degeneration.

Authors:  Michael Eisenstein
Journal:  Nature       Date:  2021-12       Impact factor: 49.962

5.  Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Barbara E K Klein; Sandra C Tomany; Scot E Moss
Journal:  Am J Epidemiol       Date:  2002-10-01       Impact factor: 4.897

Review 6.  Prospects for cannabinoids as anti-inflammatory agents.

Authors:  Robert B Zurier
Journal:  J Cell Biochem       Date:  2003-02-15       Impact factor: 4.429

7.  Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.

Authors:  Emily Y Chew; Traci E Clemons; Elvira Agrón; Robert D Sperduto; John Paul Sangiovanni; Natalie Kurinij; Matthew D Davis
Journal:  Ophthalmology       Date:  2013-04-10       Impact factor: 12.079

Review 8.  The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective.

Authors:  Syed S Mahmood; Daniel Levy; Ramachandran S Vasan; Thomas J Wang
Journal:  Lancet       Date:  2013-09-29       Impact factor: 79.321

9.  Genetic Factors, Adherence to Healthy Lifestyle Behavior, and Risk of Invasive Breast Cancer Among Women in the UK Biobank.

Authors:  Rhonda S Arthur; Tao Wang; Xiaonan Xue; Victor Kamensky; Thomas E Rohan
Journal:  J Natl Cancer Inst       Date:  2020-09-01       Impact factor: 13.506

Review 10.  Cannabinoids and the eye.

Authors:  Michael T M Wang; Helen V Danesh-Meyer
Journal:  Surv Ophthalmol       Date:  2020-08-04       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.